The embolization coils market size has grown steadily in recent years. It will grow from $1.5 billion in 2025 to $1.56 billion in 2026 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to increase in prevalence of cerebral aneurysms, growing adoption of minimally invasive embolization techniques, expansion of interventional radiology practices, improved clinical outcomes with coil embolization, increasing availability of trained neurointerventional specialists.
The embolization coils market size is expected to see steady growth in the next few years. It will grow to $1.82 billion in 2030 at a compound annual growth rate (CAGR) of 3.8%. The growth in the forecast period can be attributed to rising incidence of vascular disorders, increasing use of embolization in oncology treatments, growing demand for safer alternatives to open surgery, expansion of neurovascular treatment centers, continued innovation in coil design and materials. Major trends in the forecast period include rising adoption of endovascular treatment for brain aneurysms, growing preference for detachable embolization coils, expansion of embolization procedures across multiple specialties, increasing use of advanced coil materials for improved occlusion, rising demand for minimally invasive vascular interventions.
The increasing prevalence of chronic illnesses is anticipated to drive the growth of the embolization coils market in the future. This rise in chronic illnesses is primarily attributed to aging populations and lifestyle factors such as poor diet, lack of physical activity, and increased stress. Furthermore, advancements in diagnostics and longer life expectancies contribute to the higher number of reported cases. Embolization coils are used in treating chronic illnesses such as coronary artery aneurysms and fistulas by occluding these abnormal connections, thus preventing complications such as rupture. For example, in April 2025, according to the NHS Confederation, a UK-based national association, it is estimated that by 2035, 17% of the UK population could be living with four or more chronic conditions. Therefore, the increase in the prevalence of chronic illnesses is expected to drive the growth of the embolization coils market.
Major companies operating in the embolization coils market are focusing on developing innovative solutions, such as high-specification ultra-flexible coil systems, to enhance treatment precision and accommodate diverse aneurysm shapes. High-specification ultra-flexible coil systems are engineered in a wide range of sizes and softness levels, featuring a highly conformable structure that minimizes stress on the aneurysm wall. For instance, in August 2025, MicroPort NeuroScientific Corp., a China-based provider of neurovascular interventional devices, launched the NUMEN Coil Embolization System in Egypt. This neurovascular device is designed to treat intracranial aneurysms by occluding them with coils made from ultra-fine platinum-tungsten wire. Its unique three-dimensional structure offers flexibility and support, reducing pressure on aneurysm walls and adapting to various aneurysm shapes. Clinically, it delivers high aneurysm occlusion rates with low complication risks, improving patient outcomes in minimally invasive neuro-interventional procedures.
In November 2023, The Cooper Companies Inc., a US-based medical device company, acquired select Cook Medical assets for $300 million. This acquisition strengthens CooperSurgical's medical device portfolio and enhances its market position. Cook Medical is a US-based manufacturer of embolization coils.
Major companies operating in the embolization coils market are Johnson & Johnson Services Inc., Medtronic Plc, Heraeus Holding, Boston Scientific Corporation, Terumo Corporation, Kaneka Corporation, Cook Medical LLC, MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co. Ltd., MicroVention Inc., Balt USA LLC, InNeuroCo Inc., Wallaby Medical Inc., Rapid Medical Ltd., Spartan Micro Inc., QXMedical LLC, EmbolX Inc., Shape Memory Medical Inc., Blockade Medical LLC, Achieva Medical Co.
North America was the largest region in the embolization coils market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the embolization coils market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the embolization coils market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the embolization coils market by increasing costs for imported platinum, alloy materials, and precision manufacturing components used in coil production. These impacts are most evident in detachable and advanced material-based coil segments, particularly in hospitals and specialized neurovascular centers across regions dependent on global supply chains such as Asia-Pacific and Europe. Higher tariffs have moderately increased procedural device costs and procurement budgets. However, tariffs are also encouraging local manufacturing, alternative material sourcing, and regional production expansion, supporting long-term supply stability.
The embolization coils market research report is one of a series of new reports that provides embolization coils market statistics, including embolization coils industry global market size, regional shares, competitors with a embolization coils market share, detailed embolization coils market segments, market trends and opportunities, and any further data you may need to thrive in the embolization coils industry. This embolization coils market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Embolization coils are small metallic devices used in medical procedures known as embolization, aimed at obstructing or reducing blood flow to specific areas of the body. They are crucial in treating conditions such as brain aneurysms, arteriovenous malformations (AVMs), and arteriovenous fistulas by occluding blood vessels and preventing potential rupture or bleeding.
The main types of embolization coils include detachable coils and pushable coils. Detachable embolization coils are utilized in interventional radiology for treating aneurysms and other vascular abnormalities. They are typically composed of materials such as platinum, platinum with hydrogel, or platinum tungsten alloy. These coils find applications in neurology, urology, peripheral vascular disease, oncology, cardiology, and other medical fields. They are used by various end-users including hospitals, ambulatory centers, cardiovascular centers, and others.
The embolization coils market consists of sales of bare metal coils, fibered coils, micro coils, and liquid embolics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The embolization coils market size is expected to see steady growth in the next few years. It will grow to $1.82 billion in 2030 at a compound annual growth rate (CAGR) of 3.8%. The growth in the forecast period can be attributed to rising incidence of vascular disorders, increasing use of embolization in oncology treatments, growing demand for safer alternatives to open surgery, expansion of neurovascular treatment centers, continued innovation in coil design and materials. Major trends in the forecast period include rising adoption of endovascular treatment for brain aneurysms, growing preference for detachable embolization coils, expansion of embolization procedures across multiple specialties, increasing use of advanced coil materials for improved occlusion, rising demand for minimally invasive vascular interventions.
The increasing prevalence of chronic illnesses is anticipated to drive the growth of the embolization coils market in the future. This rise in chronic illnesses is primarily attributed to aging populations and lifestyle factors such as poor diet, lack of physical activity, and increased stress. Furthermore, advancements in diagnostics and longer life expectancies contribute to the higher number of reported cases. Embolization coils are used in treating chronic illnesses such as coronary artery aneurysms and fistulas by occluding these abnormal connections, thus preventing complications such as rupture. For example, in April 2025, according to the NHS Confederation, a UK-based national association, it is estimated that by 2035, 17% of the UK population could be living with four or more chronic conditions. Therefore, the increase in the prevalence of chronic illnesses is expected to drive the growth of the embolization coils market.
Major companies operating in the embolization coils market are focusing on developing innovative solutions, such as high-specification ultra-flexible coil systems, to enhance treatment precision and accommodate diverse aneurysm shapes. High-specification ultra-flexible coil systems are engineered in a wide range of sizes and softness levels, featuring a highly conformable structure that minimizes stress on the aneurysm wall. For instance, in August 2025, MicroPort NeuroScientific Corp., a China-based provider of neurovascular interventional devices, launched the NUMEN Coil Embolization System in Egypt. This neurovascular device is designed to treat intracranial aneurysms by occluding them with coils made from ultra-fine platinum-tungsten wire. Its unique three-dimensional structure offers flexibility and support, reducing pressure on aneurysm walls and adapting to various aneurysm shapes. Clinically, it delivers high aneurysm occlusion rates with low complication risks, improving patient outcomes in minimally invasive neuro-interventional procedures.
In November 2023, The Cooper Companies Inc., a US-based medical device company, acquired select Cook Medical assets for $300 million. This acquisition strengthens CooperSurgical's medical device portfolio and enhances its market position. Cook Medical is a US-based manufacturer of embolization coils.
Major companies operating in the embolization coils market are Johnson & Johnson Services Inc., Medtronic Plc, Heraeus Holding, Boston Scientific Corporation, Terumo Corporation, Kaneka Corporation, Cook Medical LLC, MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co. Ltd., MicroVention Inc., Balt USA LLC, InNeuroCo Inc., Wallaby Medical Inc., Rapid Medical Ltd., Spartan Micro Inc., QXMedical LLC, EmbolX Inc., Shape Memory Medical Inc., Blockade Medical LLC, Achieva Medical Co.
North America was the largest region in the embolization coils market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the embolization coils market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the embolization coils market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the embolization coils market by increasing costs for imported platinum, alloy materials, and precision manufacturing components used in coil production. These impacts are most evident in detachable and advanced material-based coil segments, particularly in hospitals and specialized neurovascular centers across regions dependent on global supply chains such as Asia-Pacific and Europe. Higher tariffs have moderately increased procedural device costs and procurement budgets. However, tariffs are also encouraging local manufacturing, alternative material sourcing, and regional production expansion, supporting long-term supply stability.
The embolization coils market research report is one of a series of new reports that provides embolization coils market statistics, including embolization coils industry global market size, regional shares, competitors with a embolization coils market share, detailed embolization coils market segments, market trends and opportunities, and any further data you may need to thrive in the embolization coils industry. This embolization coils market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Embolization coils are small metallic devices used in medical procedures known as embolization, aimed at obstructing or reducing blood flow to specific areas of the body. They are crucial in treating conditions such as brain aneurysms, arteriovenous malformations (AVMs), and arteriovenous fistulas by occluding blood vessels and preventing potential rupture or bleeding.
The main types of embolization coils include detachable coils and pushable coils. Detachable embolization coils are utilized in interventional radiology for treating aneurysms and other vascular abnormalities. They are typically composed of materials such as platinum, platinum with hydrogel, or platinum tungsten alloy. These coils find applications in neurology, urology, peripheral vascular disease, oncology, cardiology, and other medical fields. They are used by various end-users including hospitals, ambulatory centers, cardiovascular centers, and others.
The embolization coils market consists of sales of bare metal coils, fibered coils, micro coils, and liquid embolics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Embolization Coils Market Characteristics
3. Embolization Coils Market Supply Chain Analysis
4. Global Embolization Coils Market Trends and Strategies
5. Embolization Coils Market Analysis of End Use Industries
7. Global Embolization Coils Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Embolization Coils Total Addressable Market (TAM) Analysis for the Market
9. Embolization Coils Market Segmentation
10. Embolization Coils Market Regional and Country Analysis
11. Asia-Pacific Embolization Coils Market
12. China Embolization Coils Market
13. India Embolization Coils Market
14. Japan Embolization Coils Market
15. Australia Embolization Coils Market
16. Indonesia Embolization Coils Market
17. South Korea Embolization Coils Market
18. Taiwan Embolization Coils Market
19. South East Asia Embolization Coils Market
20. Western Europe Embolization Coils Market
21. UK Embolization Coils Market
22. Germany Embolization Coils Market
23. France Embolization Coils Market
24. Italy Embolization Coils Market
25. Spain Embolization Coils Market
26. Eastern Europe Embolization Coils Market
27. Russia Embolization Coils Market
28. North America Embolization Coils Market
29. USA Embolization Coils Market
30. Canada Embolization Coils Market
31. South America Embolization Coils Market
32. Brazil Embolization Coils Market
33. Middle East Embolization Coils Market
34. Africa Embolization Coils Market
36. Embolization Coils Market Competitive Landscape and Company Profiles
37. Embolization Coils Market Other Major and Innovative Companies
40. Embolization Coils Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Embolization Coils Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses embolization coils market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for embolization coils? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The embolization coils market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Detachable Coil; Pushable Coil2) By Material: Platinum; Platinum And Hydrogel; Platinum Tungsten Alloy
3) By Application: Neurology; Urology; Peripheral Vascular Disease; Oncology; Cardiology; Other Applications
4) By End-User: Hospitals; Ambulatory Center; Cardio Center; Other End-Users
Subsegments:
1) By Detachable Coil: Mechanical Detachable Coils; Electrothrombogenic Detachable Coils; Hydrogel-Coated Detachable Coils2) By Pushable Coil: Bare Pushable Coils; Coiled Pushable Coils; Soft Pushable Coils
Companies Mentioned: Johnson & Johnson Services Inc.; Medtronic Plc; Heraeus Holding; Boston Scientific Corporation; Terumo Corporation; Kaneka Corporation; Cook Medical LLC; MicroPort Scientific Corporation; Penumbra Inc.; Asahi Intecc Co. Ltd.; MicroVention Inc.; Balt USA LLC; InNeuroCo Inc.; Wallaby Medical Inc.; Rapid Medical Ltd.; Spartan Micro Inc.; QXMedical LLC; EmbolX Inc.; Shape Memory Medical Inc.; Blockade Medical LLC; Achieva Medical Co
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Embolization Coils market report include:- Johnson & Johnson Services Inc.
- Medtronic Plc
- Heraeus Holding
- Boston Scientific Corporation
- Terumo Corporation
- Kaneka Corporation
- Cook Medical LLC
- MicroPort Scientific Corporation
- Penumbra Inc.
- Asahi Intecc Co. Ltd.
- MicroVention Inc.
- Balt USA LLC
- InNeuroCo Inc.
- Wallaby Medical Inc.
- Rapid Medical Ltd.
- Spartan Micro Inc.
- QXMedical LLC
- EmbolX Inc.
- Shape Memory Medical Inc.
- Blockade Medical LLC
- Achieva Medical Co
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.56 Billion |
| Forecasted Market Value ( USD | $ 1.82 Billion |
| Compound Annual Growth Rate | 3.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
